1. Home
  2. LIXT vs FMST Comparison

LIXT vs FMST Comparison

Compare LIXT & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$7.00

Market Cap

26.5M

Sector

Health Care

ML Signal

HOLD

Logo Foremost Lithium Resource & Technology Ltd.

FMST

Foremost Lithium Resource & Technology Ltd.

HOLD

Current Price

$1.50

Market Cap

30.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIXT
FMST
Founded
2005
2005
Country
United States
Canada
Employees
3
2
Industry
Biotechnology: Pharmaceutical Preparations
Other Metals and Minerals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
26.5M
30.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LIXT
FMST
Price
$7.00
$1.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
140.9K
105.3K
Earning Date
05-08-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$1.48
52 Week High
$7.50
$4.98

Technical Indicators

Market Signals
Indicator
LIXT
FMST
Relative Strength Index (RSI) 67.55 40.34
Support Level $2.92 $1.51
Resistance Level N/A $1.96
Average True Range (ATR) 0.82 0.13
MACD 0.07 0.00
Stochastic Oscillator 82.94 12.20

Price Performance

Historical Comparison
LIXT
FMST

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About FMST Foremost Lithium Resource & Technology Ltd.

Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.

Share on Social Networks: